Log In
Print
BCIQ
Print
Print this Print this
 

Budenofalk (Budesonide gastro-resistant capsule)

  Manage Alerts
Collapse Summary General Information
Company Dr. Falk Pharma GmbH
Description3 mg budesonide gastro resistant capsules
Molecular Target Corticoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$15,624.0M

$14,789.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today